gene

mme

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about mme: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

20Connections
6Hypotheses
2Analyses
13Outgoing
7Incoming
0Experiments
2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolMME
AliasesNeprilysin/CD10
Chromosome3q25.2
Protein TypeProtease
Amino Acids750 aa
Exons24
Ensembl IDENSG00000196549
GeneCardsMME
Human Protein AtlasMME
Degrades Aβ40 and Aβ42the primary pathogenic peptides in alzheimers — by cleaving at multiple sites within the peptide
Associated Diseasesneurodegeneration
DatabasesGeneCardsUniProtNCBI GeneHPASTRING
🧬 3D Structure: mme — PDB 1DMT Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Wiki Pages (10)

Knowledge base pages for this entity

Canonical Page

MME (Membrane Metalloendopeptidase / Neprilysin)

gene · 2276 words

Section 233: Advanced Virtual Reality and Immersive Technology-Based Rehabilitation in CBS/PSP

therapeutic · 3946 words

PDCD10 Gene (Programmed Cell Death 10)

gene · 2983 words

semmelweis-university

institution · 2553 words

Shimmer

company · 2189 words

Roemmers

company · 1276 words

Pathway Diagram

graph TD
    MME["MME"]
    MME -->|"regulates"| Alzheimer["Alzheimer"]
    MME -->|"regulates"| Als["Als"]
    MME -->|"regulates"| ALS["ALS"]
    MME -->|"regulates"| ALZHEIMER["ALZHEIMER"]
    MME -->|"regulates"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    MME -->|"regulates"| Hemoglobin["Hemoglobin"]
    MME -->|"implicated in"| neurodegeneration["neurodegeneration"]
    ALZHEIMER -->|"regulates"| MME

Outgoing (13)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:MMEdata_indataset_row0.00
ALSregulatesdisease0.65
Alzheimerregulatesdisease0.65
Alsregulatesdisease0.65
ALZHEIMER'S DISEASEregulatesgene0.60

Incoming (7)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:MMEdata_indataset_row0.00
SORL1associated_withgene0.60
HBBassociated_withgene0.60
GAPDHassociated_withgene0.60
GENESassociated_withgene0.60

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Seed-Proximal Asymmetric Duplex Stability Confers lncRNA-002 0.733 molecular-neurobiology How does lncRNA-0021 achieve sequence-sp
Neuronal TET1 Upregulation Reactivates Immediate-Early Genes 0.640 neurodegeneration epigenetic reprogramming aging neurons
Butyrate-Producing Commensal Depletion Creates Vicious Cycle 0.630 neurodegeneration How does gut microbiome dysbiosis contri
Charge-Pattern Asymmetry Creates Electrostatic Recruitment G 0.523 molecular-biology What physicochemical properties determin
Phosphatidylserine Decarboxylase (PISD) Restoration to Corre 0.342 lipidomics Lipid metabolism dysregulation in Alzhei
Tau-Induced Lipid Membrane Asymmetry Exploitation 0.000 - How can ESCRT or SNARE targeting achieve

Mentioning Analyses (2)

Scientific analyses that reference this entity

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.634

Does tau aggregation specifically cause PS externalization in vesicles independe

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The debate revealed a fundamental gap in understanding whether tau pathology dir

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The abstract challenges the rationale for using microtubule-stabilizing drugs in

closed · Rounds: 4 · Score: 0.68 · 2026-04-15

Related Research

Hypotheses and analyses mentioning mme in their description or question text

Tau-Induced Lipid Membrane Asymmetry Exploitation

Score: 0.000 · unknown disease · 2026-04-28

Develop therapeutics targeting altered phospholipid asymmetry in tau-containing vesicles. Pathological tau may disrupt n